# MC10

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mc10

- Industry: Semiconductors
- Headquarters: Lexington, US
- Website: www.mc10inc.com
- Total disclosed funding: $61M
- Latest round: Series D (Dec 13, 2013)
- Investors on record: 8

## About

MC10, Inc. specializes in developing advanced wearable technologies that integrate electronics with biological systems, enabling transformative health monitoring and analysis solutions.Founded in 2008 by Roozbeh Ghaffari and headquartered in Lexington, US, MC10, Inc. focuses on innovative health technology. In October 2020, the company was acquired by Medidata Solutions, Inc. for undisclosed financial terms. Throughout its history, MC10 has engaged in 16 deals, with its most recent deal occurring on October 27, 2020. The company raised a total of USD 10.03 mn, with the latest funding round attracting investments from various firms including Aberdare Ventures and Medtronic.MC10, Inc. offers a range of wearable technologies that are designed to improve health monitoring through the integration of electronics with biological systems. These products aim to provide advanced solutions for health analysis, ensuring effective data collection and user engagement for various health applications. Their innovations cater to sectors such as continuous health monitoring and athletic performance enhancement, serving both consumers and healthcare providers.MC10, Inc. generates revenue through partnerships and the sale of its advanced wearable technologies. The company establishes long-term agreements with clients who utilize its products for health monitoring and performance analysis. Revenue models typically involve subscription-based pricing for access to MC10's technology, which supports a range of health-related applications across different markets.With the acquisition by Medidata Solutions in October 2020, MC10 plans to leverage its advanced technology to enhance product offerings and expand into new markets. The integration aims to support the development of innovative health monitoring solutions tailored for the biopharmaceutical and healthcare sectors. The recent funding of USD 10.03 mn will be utilized to further research and development efforts, focusing on launching new wearable technologies that are anticipated to meet growing demands in personalized health monitoring.

## Funding rounds

- Series D, Dec 13, 2013, $20M — BEV Capital, Aberdare Ventures, Braemar Energy Ventures
- Series C, Apr 12, 2013, $8.2M — BEV Capital, Aberdare Ventures
- Series C, Nov 30, 2012, $10M — BEV Capital, North Bridge Venture Partners, Aberdare Ventures, Braemar Energy Ventures, OUP (Osage University Partners), Medtronic, Terawatt Ventures, Windham Venture Partners
- Series B, Jan 25, 2012, $2M — Aberdare Ventures
- Series B, Aug 9, 2011, $2.4M — Windham Venture Partners
- Series B, Jun 17, 2011, $13M — North Bridge Venture Partners, Braemar Energy Ventures, OUP (Osage University Partners), Terawatt Ventures
- Series A, Jul 2, 2010, $0.6M — BEV Capital, North Bridge Venture Partners
- Series A, Dec 2, 2009, $5.7M — BEV Capital, North Bridge Venture Partners

## Investors

- BEV Capital (https://capitalatlas.ai/funds/bev-capital) — Series A, Series C, Series D
- North Bridge Venture Partners (https://capitalatlas.ai/funds/north-bridge-venture-partners) — Series A, Series B, Series C
- Braemar Energy Ventures (https://capitalatlas.ai/funds/braemar-energy-ventures) — Series B, Series C, Series D
- OUP (Osage University Partners) (https://capitalatlas.ai/funds/oup-osage-university-partners) — Series B, Series C
- Terawatt Ventures (https://capitalatlas.ai/funds/terawatt-ventures) — Series B, Series C
- Windham Venture Partners (https://capitalatlas.ai/funds/windham-venture-partners) — Series B, Series C
- Aberdare Ventures (https://capitalatlas.ai/funds/aberdare-ventures) — Series B, Series C, Series D
- Medtronic — Series C